Inpharmatica, Celera in Deal to Deliver New Protein Structure Database | GenomeWeb

LONDON, Nov. 7 - Inpharmatica and Celera Genomics said Wednesday that they had agreed to jointly develop a new database that would offer structural information about the human and mouse proteins contained in the Celera Discovery System.

Under the terms of the deal, Inpharmatica, which currently markets protein structure data through its Biopendium database, said it would use its bioinformatics tools to generate structural information from the human and mouse sequences Celera has decoded.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.